Titratable partial aortic occlusion: Extending Zone I endovascular occlusion times

David Gomez1, Asad Naveed, Joao Rezende

  • 1From the Division of General Surgery (D.G., J.R., A.B.), St. Michael's Hospital, and Li Ka Shing Knowledge Institute (D.G., A.N., J.R., A.B.), Unity Health Toronto; Department of Surgery (D.G., J.R., A.B.), Temetry Faculty of Medicine, and Institute of Health Policy, Management and Evaluation (D.G.), University of Toronto, Toronto, Ontario, Canada; Division of Acute Care Surgery (B.M.D.), Vanderbilt University Medical Center, Nashville, Tennessee; Program in Trauma (R.K.), R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Maryland; Division of Acute Care Surgery (E.B.), Grady Memorial Hospital, Atlanta, Georgia; Ernest E Moore Shock Trauma Center at Denver Health (R.L., E.E.M.), University of Colorado Denver, Denver, Colorado; Department of Surgery (J.N.), Morehouse School of Medicine, Atlanta, Georgia; Norman McSwain Trauma Center (J.D.), Tulane Acute Care Surgery, New Orleans, Louisiana; Division of Trauma and Acute Care Surgery (C.S., S.D.), Grant Medical Center, Columbus, Ohio; and Prytime Medical Devices (C.V.S.), San Antonio, Texas.

Summary

Novel devices enabling partial aortic occlusion extend resuscitation times for noncompressible torso hemorrhage (NCTH) on the battlefield. This advance is crucial for managing NCTH, a leading cause of death in combat casualties.

Related Concept Videos